GNS Attending BioTechX Europe’s Largest Congress
BioTechX is Europe’s largest congress covering latest breakthroughs in pharmaceutical development and healthcare. This year, GNS is attending this world-class congress, and our own Colin Hill will be speaking on Nov 8 at 14:50 (CET) on the Recent Application of Digital Twins in Drug Discovery and Development for Alzheimer’s Disease. Make sure to bookmark your […]
Bruce Church to Speak at the Human Vaccines Project
Over 20 years ago, the sequencing of the human genome revolutionized biomedical research and ushered in a new era of precision medicine. On September 27-29, 2022, The Human Vaccines Project will convene a summit to map out the next frontier in human biology: How to Build an AI Model of the Human Immunome. The primary […]
Colin Hill to Give Keynote at the 26th Annual Merck Technology Symposium
The Merck Technology Symposium is an annual event that brings together upwards of 2,000 scientists and over 70 external vendors to hear about innovations in new therapeutic approaches, applications of new technology, and accelerating the pace at which we deliver medicines to patients. The meeting will be organized around several tracks illustrating the various ways […]
Colin Hill moderating Fireside Chat at Longwood Healthcare Leaders Fall meeting
Once again, GNS is a proud supporter of Longwood Healthcare Leaders. This Fall webconference brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients. On Thursday, September 22, 2022, our CEO Colin Hill will be […]
Panel discussion “The State of AI in Biotech” at the State of Biotech by GEN EDGE
Join the editors of Genetic Engineering & Biotechnology News and an all-star line-up of speakers as we analyze the state of biotechnology – a celebration of innovation, emerging technologies, and clinical successes and an in-depth appraisal of the headwinds and challenges facing the industry. On Wednesday, September 21th, 2022, our CEO Colin Hill, will be on […]
Meet us at the 19th International Myeloma Society Annual Meeting
This year we are attending the 19th International Myeloma Society Annual Meeting in Los Angeles. Come meet Team GNS and our data partner Multiple Myeloma Research Foundation (MMRF) to explore how we are working together to accelerate Multiple Myeloma drug discovery and development with Al Digital Twins. Please fill out the form below and a member of our […]
Meet us at AI Drug Driven Discovery Summit
Join us at the AI Drug Driven Discovery Summit, August 16-17, 2022 in Boston. Don’t hesitate to let us know if you’d like to schedule a meeting beforehand and discuss drug discovery partnership opportunities.
Meet us at the Alzheimer’s Association International Conference – AAIC
Did you know that it is estimated that nearly 500,000 new cases of Alzheimer’s disease will be diagnosed this year in the United States? And every 3 seconds, someone in the world develops dementia. This year we are attending the Alzheimer’s Association International Conference (AAIC) in San Diego. Come meet Team GNS and our data partner the Global […]
Meet us at Precision Medicine World Conference – PMWC
We are delighted to attend PMWC annual meeting, the largest medicine conference in the world. Schedule a meeting with Team GNS if you want to hear more about how we are using data and causal AI to build our Gemini Virtual Patients in pursuit of precision medicine: https://lnkd.in/eCEqFsra
Panel discussion at BIO “Why the FDA Will Bet More on in Silico Simulations To Trigger Better Success Rates for NDAs”
Meet us this year at BIO, the largest global non-profit biotechnology trade association. On Tuesday, June 14th, our CEO Colin Hill, will be moderating a panel discussion titled “Why the FDA Will Bet More on in Silico Simulations To Trigger Better Success Rates for NDAs”. He will be joined by Andrea de Souza, AVP Global […]